Skip to main content
letter
. 2020 Jun 3;92(11):2371–2373. doi: 10.1002/jmv.26063

Figure 1.

Figure 1

Clinical courses, quantification of SARS‐CoV‐2 viral loads, and inflammatory markers in two patients (panel A and B, respectively) treated with hzVSF‐v13 in this study. CRP, C‐reactive protein; CRRT, continuous renal replacement therapy; ECMO, extracorporeal membrane oxygenation; IFN‐γ, interferon‐γ; MCP‐1, monocyte chemoattractant protein‐1; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2; TNF‐α, tumor necrosis factor‐α